Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter K Linden

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|November 5, 2003
Amphotericin B lipid complex for the treatment of invasive fungal infectionsPeter K Linden
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing therapy for vancomycin-resistant enterococci (VRE)Peter K Linden
Expert Review of Anti-Infective Therapy|December 5, 2008
Vancomycin resistance: are there better glycopeptides coming?Peter K Linden
Critical Care Clinics|March 10, 2009
History of solid organ transplantation and organ donationPeter K Linden
Infectious Disease Clinics of North America|August 12, 2009
Approach to the immunocompromised host with infection in the intensive care unitPeter K Linden
Drugs|February 6, 2002
Treatment options for vancomycin-resistant enterococcal infectionsPeter K Linden
Drugs|July 20, 2004
Newer treatment options for skin and soft tissue infectionsMurugan Raghavan, Peter K Linden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2006
Parenteral and inhaled colistin for treatment of ventilator-associated pneumoniaPeter K Linden, David L Paterson
Critical Care (London, England)|August 16, 2017
Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatmentAli Hassoun, Peter K Linden, Bruce Friedman
Critical Care (London, England)|May 25, 2007
Steroids in early ARDS?Tarek Aldabbagh, Eric B Milbrandt, Peter K Linden
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|November 5, 2003
Amphotericin B lipid complex for the treatment of invasive fungal infectionsPeter K Linden
Seminars in Respiratory and Critical Care Medicine|December 21, 2007
Optimizing therapy for vancomycin-resistant enterococci (VRE)Peter K Linden
Expert Review of Anti-Infective Therapy|December 5, 2008
Vancomycin resistance: are there better glycopeptides coming?Peter K Linden
Critical Care Clinics|March 10, 2009
History of solid organ transplantation and organ donationPeter K Linden
Infectious Disease Clinics of North America|August 12, 2009
Approach to the immunocompromised host with infection in the intensive care unitPeter K Linden
Drugs|February 6, 2002
Treatment options for vancomycin-resistant enterococcal infectionsPeter K Linden
Drugs|July 20, 2004
Newer treatment options for skin and soft tissue infectionsMurugan Raghavan, Peter K Linden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2006
Parenteral and inhaled colistin for treatment of ventilator-associated pneumoniaPeter K Linden, David L Paterson
Critical Care (London, England)|August 16, 2017
Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatmentAli Hassoun, Peter K Linden, Bruce Friedman
Critical Care (London, England)|May 25, 2007
Steroids in early ARDS?Tarek Aldabbagh, Eric B Milbrandt, Peter K Linden
Pageof 3